Abstract
Matrix metalloproteinase-2 (MMP-2) is an enzyme with proteolytic activity on matrix proteins, and previous studies have revealed a strong association between the MMP-2 −1306C→T polymorphism and the risk of several types of cancer. Our study looked at whether this polymorphism contributed to the development of cervical neoplasia by analyzing 54 patients with invasive squamous cell cervical cancer, 100 patients with cervical intraepithelial neoplasia, and 126 control subjects. The MMP-2 CC genotype was more frequent in the cancer patients when compared with the control group (OR 2.57; 95% CI 1.15–5.86). The association of cervical cancer with the CC genotype was more pronounced in women who had first coitus at an early age (OR 3.96; 95% CI 1.46–11.06). The CC genotype was associated with intraepithelial neoplasia only in women with first coitus at 19 years old or younger. The data suggest that the MMP-2 −1306C→T polymorphism contributes to the development of squamous cell cervical cancer in the population studied, especially in women who had first coitus at an early age.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ahmed MI, Salahy EE, Tawfiq H, Khalifa A, Hassan MM (2004) Matrix metalloproteinase-2, squamous cell carcinoma antigen, and tissue polypeptide-specific antigen expression in Egyptian patients with cervical carcinoma: relationship with prognosis. Dis Markers 20:333–343
Collins SI, Mazloomzadeh S, Winter H, Rollason TP, Blomfield P, Young LS, Woodman CB (2005) Proximity of first intercourse to menarche and the risk of human papillomavirus infection: a longitudinal study. Int J Cancer 114:498–500
Curran S, Murray GI (1999) Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 189:300–308
Delgado-Enciso I, Cepeda-Lopez FR, Monrroy-Guizar EA, Bautista-Lam JR, Andrade-Soto M, Jonguitud-Olguin G, Rodriguez-Hernandez A, Anaya-Ventura A, Baltazar-Rodriguez LM, Orozco-Ruiz M, Soriano-Hernandez AD, Rodriguez-Sanchez IP, Lugo-Trampe A, Espinoza-Gomez F, Michel-Peregrina ML (2008) Matrix metalloproteinase-2 promoter polymorphism is associated with breast cancer in a Mexican population. Gynecol Obstet Invest 65:68–72
Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174
Elander N, Soderkvist P, Fransen K (2006) Matrix metalloproteinase (MMP)-1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26:791–795
Franceschi S (2005) The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res 166:277–297
Gaiotto MA, Focchi J, Ribalta JL, Stavale JN, Baracat EC, Lima GR, Guerreiro da Silva ID (2004) Comparative study of MMP-2 (matrix metalloproteinase 2) immune expression in normal uterine cervix, intraepithelial neoplasias, and squamous cell cervical carcinoma. Am J Obstet Gynecol 190:1278–1282
Kahn JA, Rosenthal SL, Succop PA, Ho GY, Burk RD (2002) Mediators of the association between age of first sexual intercourse and subsequent human papillomavirus infection. Pediatrics 109:E5
Lin SC, Lo SS, Liu CJ, Chung MY, Huang JW, Chang KW (2004) Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med 33:405–409
Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, Lin D (2003) A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res 63:3987–3990
Nasr M, Ayyad SB, El-Lamie IK, Mikhail MY (2005) Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix. Eur J Gynaecol Oncol 26:199–202
Prescrire Int (2007) Human papillomavirus: often harmless but in some cases carcinogenic. Prescrire Int 16:115–119
Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558
Qin H, Sun Y, Benveniste EN (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274:29130–29137
Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10:415–433
Tavassoéli FA, Devilee P (2003) World Health Organization: tumours of the breast and female genital organs (who/IARC classification of tumours). IARC Press, Lyon France
Woessner JF (1991) Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154
Xu EP, Huang Q, Lu BJ, Xing XM, Lai MD (2006) The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23:78–81
Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L, Lin D (2002) Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62:6430–6433
Zhou Y, Yu C, Miao X, Tan W, Liang G, Xiong P, Sun T, Lin D (2004) Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis 25:399–404
Acknowledgment
This work was supported by “Ramon Alvarez Buylla de Aldana” Grants (343/05; 511/07) from the University of Colima.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baltazar-Rodriguez, L.M., Anaya-Ventura, A., Andrade-Soto, M. et al. Polymorphism in the Matrix Metalloproteinase-2 Gene Promoter is Associated with Cervical Neoplasm Risk in Mexican Women. Biochem Genet 46, 137–144 (2008). https://doi.org/10.1007/s10528-007-9136-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-007-9136-4